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Abstract  
Heart transplant patients are followed for up to a year with periodic right heart catheterizations 
(RHCs) to identify post-transplant complications and guide treatment. Positive outcomes are 
associated with a steady reduction of right ventricular and pulmonary artery pressure post-
transplant toward normal levels of right-side pressure (about 20mmHg) as measured by right 
heart catheterization. However, standard RHC measures have the potential to identify much more 
about the progression of the cardiovascular state during recovery if combined with mechanistic 
computational cardiovascular system models. The purpose of this study is two-fold: to 
understand how cardiovascular system models can be used to represent a patient's cardiovascular 
state and to use these models on a subset of patients where we have longitudinal RHCs over the 
span of the first year to track post-transplant recovery and outcome. The cardiovascular systems 
model used here and its underlying mechanistic parameters are evaluated using sensitivity 
analysis, parameter subset selection and parameter identifiability to understand what information 
about the cardiovascular state can be reliably extracted from RHC data. Patient-specific models 
are then identified for ten patients from their first post-transplant RHC. Parameters representing 
ventricular diastolic filling, systemic resistance, pulmonary vein elastance, pulmonary resistance, 
pulmonary artery elastance, pulmonary valve resistance and aortic elastance are identified for 
each patient using this approach. Multiple RHCs from five of these patients are analyzed 
longitudinally to visualize progression of recovery using simulated left and right ventricular 
pressure-volume loops exhibiting the potential for this method to understand post-transplant 
remodeling and recovery of the entire cardiovascular system.  
Introduction 
Better outcomes for patients with cardiovascular pathophysiologies are currently being driven by 
an increasing number of clinical measures (both noninvasive and invasive) to determine 
diagnoses and guide treatment. These measures are correlated to successful therapeutic strategies 
for a given condition, but the underlying physiological mechanisms involved in the success of a 
given treatment for a given patient are often not explicitly determined. An example is the 
assessment of cardiovascular function using right heart catheterization measures after heart 
transplant. Repeated right heart catheterization (RHC) measurements of ventricular and 
pulmonary arterial pressure are used to monitor post-transplant pulmonary hypertension, which if 
not resolved or increases in magnitude can lead to complications in post-transplant recovery1-4. 
These measurements are used to inform post-transplant treatment and intervention and have been 
associated with better outcome, yet they only provide a description of the upper level phenotype 
of the cardiovascular system and do not take advantage of the relationships that exist in the 
cardiovascular system between pressures, volumes and flow. It has been suggested5, 6, that a 
more complete evaluation of the cardiovascular state and detection of dysfunction in the 
transplanted heart could foster even better outcomes. This study builds a computational 
methodology for utilizing current clinical measures to provide estimates of the pressure, flow, 
and volume in the cardiovascular system along with mechanistic functional parameters, which 
can aid in prediction of heart transplant outcome and guide corrective treatment.  
In addition to RHC measurements, echocardiography, magnetic resonance imaging and Doppler 
imaging have been used to track metrics of cardiac function post-transplantation7-10. However, 
the use of these non-invasive modalities has not supplanted the standard clinical sequence of 
RHC measures for the evaluation of cardiovascular function post-transplant. In one study 
utilizing tissue Doppler the non-invasive measurements were simply used to optimally time 
when the RHC were to be obtained in heart transplant patients7. These prospective studies focus 
on a single measure of interest or biomarker, which is hypothesized to be able to guide therapy. 
A clinical study is then designed to measure this biomarker and a correlation to outcome is 
hopefully made. This approach is problematic in two ways. First, this methodology is inefficient 
since if the prospective biomarker does not discriminate outcomes, another biomarker must be 
selected and the process is repeated . Secondly, this approach ignores the fact that post-transplant 
recovery and outcome are multifactorial in nature involving the function of the entire 
cardiovascular system working in conjunction with the transplanted heart. 
Since information from electronic health records (EHRs) are now being deidentified and made 
available to researchers, large sets of data can now be assembled to perform analyses in a 
retrospective manner where the clinical outcome is already known. These research-ready 
repositories of EHR data are currently being assembled at the University of Michigan (Data 
Office for Clinical and Translational Research, DOCTR) and at other institutions facilitate access 
to clinical measures such as the RHC data from heart transplant patients used in this study. 
Moving forward, combinations of clinical measures from EHRs have the potential to be used to 
find correlations with clinical outcome in a statistical sense. Better yet, as we are doing in this 
study, we combine clinical measures from EHRs with computational modeling to providing 
mechanistic representation of individual patient function extracting correlations of lower level 
functional phenotypes with patient outcome. The implementation of this mechanistic 
representation is through the use of mathematical models of cardiovascular physiology, which 
have been developed and refined over several decades11-13.  
Figure 1 illustrates our overall goals of this study where RHC data is accessed and then analyzed 
with computational models to provide patient specific instantiations of the model that are used to 
predict function that cannot be measured clinically. A key part of this study is to verify if given a 
limited set of data extracted from a typical heart transplant patient’s EHR we can create a patient 
specific instantiation of a mathematical model of cardiovascular system dynamics. One 
important point of this exploration is to select the granularity of model which can be informed by 
the clinical data and then quantify the degree to which the identified parameters in the model can 
be uniquely specified. These patient specific instantiations of the mathematical model may be 
used to infer underlying differences between patients, which can be used to understand how 
changes in cardiovascular function are associated with outcome. By overlaying our physiological 
knowledge of the cardiovascular system with patient specific data we are constraining the system 
to represent an individual patient. Since this is a retrospective analysis this approach opens the 
potential to search for early indicators of positive and negative heart transplant outcomes on 
record in the EHRs.  
In this proof of concept study, we employ a mechanistic computational model of cardiovascular 
physiology inspired by the model developed by Smith et al.12 to identify model parameters 
informed by RHC and aortic blood pressure measurements from ten heart transplant patients. 
The model used here is developed wiht available RHC data that does not contain any pressure 
waveforms and does not include any direct measures of left ventricular function. In this model, a 
detailed selection of identifiable parameters is made using sensitivity and correlation analysis of 
the model parameters with respect to the available data. After an identifiable subset of model 
parameters is selected the initial post-transplant RHC datasets from each of the ten patients 
records are then used to produce patient-specific models. Of the ten patients’ datasets, five 
contain longitudinal RHC measurements at an additional 3-7 post-transplant timepoints over the 
span of 12 months. We then analyze these longitudinal RHC measures from these five patients to 
quantify how underlying cardiovascular function for each patient is changing during post-
transplant recovery. 
Methods 
RHC measures: The RHC data was extracted from the clinical data repository at the University 
of Washington Medicine Regional Heart Center. This retrospective data capture was approved 
by the Institutional Review Board (IRB) at the University of Washington. The data in the 
repository was exported from the Mac-Lab Hemodynamic Recording System (GE Healthcare, 
Chicago, IL, USA) used in the UW cardiac catheterization lab. The repository was queried for 
RHC datasets from heart transplant patients with catheterization procedures performed between 
March 6, 2014 to March 21, 2016. Ten patient records were retrieved and of these, five records 
contained multiple RHC measures from a four- to twelve-month period immediately following 
the transplant. The selected datasets contained twelve clinically measured values: systolic and 
diastolic pressure measured in the right ventricle, the main pulmonary artery, and the aorta; an 
average pulmonary capillary wedge pressure, heart rate, cardiac output, body weight, height, and 
gender, as shown in Table 1 (Table S1 of the supplementary material gives all data used in this 
study including longitudinal RHC data for a subset of the patients). The clinical data repository 
also includes estimates for systemic vascular and pulmonary vascular resistance in these patients 
however, these measures in the EHR are not true measures but are calculated from a subset of the 
twelve clinical measures listed above, and are therefore not used in this study, as these quantities 
can directly be extracted from model predictions.  
Mathematical model: In the style of the model by Smith et al.12, we developed a cardiovascular 
systems level model (shown in Figure 2) to study patient-specific cardiovascular function in 
heart transplant patients. To avoid overparameterization our aim was to set up the simplest model 
that can simulate the RHC and aortic blood pressure data. The main differences between our 
model and the one by Smith et al.12 is that (1) we ignored the influence of right ventricular and 
left ventricular pressure on the cardiovascular function otherwise known as ventricular-
ventricular interaction (VVI) and (2) the inertance of blood flowing through the four heart 
valves. We justified the former using simple sensitivity analysis by doubling and halving 
parameters involved with VVI around nominal values for several of our patients. Low sensitivity 
of the parameters involved with ventricular-ventricular interaction did not justify the significant 
increase in model complexity. Inertance of blood flowing through the four valves in the heart 
could be of importance to prediction of waveforms (especially the aortic pressure waveform); 
however, the RHC measures are not given as waveforms in the EHR but simply maximal and 
minimal pressures in systole and diastole respectively and therefore do not contain the 
information needed to identify inertance parameters. 
The cardiovascular system model depicted in Figure 2 is used to predict blood pressure, flow, 
and volume in the heart’s left and right ventricles, and the pulmonary and systemic arteries and 
veins. The model is analogous to an RC electrical circuit where current is represented by blood 
flow (!), voltage by pressure ("), and charge by volume (#). In addition, elastance ($) is 
reciprocal of compliance and represents capacitance, while resistance (%) between two 
compartments represents the resistance of the blood passing through capillaries or a heart valve 
and is analogous to electrical resistance. Diodes are used to simulate one-way valves preventing 
blood from exiting the ventricles in the wrong direction. The muscle contractions within the 
heart are modeled using an exponential activation function defined over one cardiac cycle as 	$(() = 	 +,-(.,/)0	, (1) 
where 2 is the heart rate and 3	is half the length of the cardiac cycle (4 = 1/2). This creates a 
symmetric curve about 3 bounded by 0 ≤ $(() ≤ 1 and denotes the phase of the cardiac cycle. 
The end systolic pressure ("9:) and volume (#9:) in the left and right ventricles are assumed to be 
linearly related by the end-systolic ventricular elastance ($9:) via "9: = $9:(#9: − #<), (2) 
where #< is the end systolic volume at zero pressure. Similarly, the end diastolic pressure ("9<) is 
related nonlinearly to end diastolic volume (#9<) by "9< = "=(+>(?@A,?B) − 1) (3) 
where "= is the pressure at the unstressed volume #=, and C is the exponential constant. 
Combining Eq. (2) and (3) gives "(() = $(() ⋅ "9: + F1 − $(()G ⋅ "9< + ".H, (4) 
which calculates the pressure in each ventricle where ".H is the tissue pressure in the thoracic 
cavity. As $(() oscillates through the cardiac cycle, Eq. (4) weighs the contributions of the 
systolic and diastolic pressure to give the total pressure in the ventricle. Since the pulmonary 
arteries and veins are located in the thoracic cavity, the pressure and volume are related as " = $# + ".H, (5) 
while the majority of the systemic arteries and veins are outside the thoracic cavity, giving " = $#. (6) 
Blood flow in and out of each compartment is proportional to the difference in surrounding 
pressure and is derived from Ohm’s Law 
! = "JK − "LM.%  (7) 
and conservation of volume implies N#N( = !JK − !LM. (8) 
for each compartment. To model the one-way heart valves, we must restrict flow when the valve 
should be closed, giving  
!OPQO9 = R"JK − "LM.%OPQO9 					if	"JK > "LM.		0																otherwise   (9) 
for the aortic (]^), tricuspid ((_), pulmonary (`^), and mitral (a() valves. A list of equations 
making up the model is given in Appendix A and a version of the model implemented in 
MATLAB is available at  https://wp.math.ncsu.edu/cdg/. In summary, the system of equations 
can be written in the form NbN( = c(b, (; e)		 b = f#QO, #PL, #Og, #hO, #iP, #iMj e = {2, 3, $QO, #<,QO, "=,QO, CQO, #=,QO, $hO, #<,hO, "=,hO, ChO, #=,hO,											$iP, $iM, %iMQ, ".H, $PL, $Og, %:l:, %m., %PO, %.g, %iO} o = {"QO, "hO, "iP, "iM, "PL, "Og, #QO, #hO, #iP, #iM, #PL, #Og, !:l:}. 
The model output o = p(b, (; e) + q, where q is model noise assumed to be independent and 
identically distributed. 
Initial Conditions and Nominal Parameter Values: Initial conditions and nominal parameter 
values (Table 2) are extracted from the clinical data and literature using an approach similar to 
the one outlined in Marquis et al.14 translated to analysis of human data.  
Blood volume: The total blood volume (TBV in mL)15 and body surface area (BSA in m2)16 as 
functions of height (Hgt in cm), weight (BW in kg), and gender given as 
TBV = u (0.3669	⋅	Hgt{ + 0.03219 ⋅ BW + 0.641) ⋅ 1000					for	males(0.3561	⋅	Hgt{ + 0.03308 ⋅ BW + 0.1833) ⋅ 1000					for	females (10) 
BSA = Ü 0.0005795 ⋅ BW0.38	⋅	Hgt1.24					for	males0.0009755 ⋅ BW0.46	⋅	Hgt1.08								for	females (11) 
Compartment models as the one presented here only track stressed volume, which for mice 
amount to approximately 30% of the total blood volume17-19. Of this stressed volume, 6.5% is 
housed in the left ventricle, 5.5% in the right ventricle, 3% in the pulmonary artery, 54% in the 
pulmonary vein, 9% in the aorta, and 22% in the vena cava18. The parameters used in Eqs. (2) 
and (3) listed in Table 2 are calculated from data and extracted from literature. 
Pressure: For compartments for which we do not have data, we relate quantities to values in the 
anterior or posterior compartment. We assume the pulse pressure of the pulmonary vein is 20% 
of the pulmonary artery, and that the systolic pulmonary vein pressure is the pulmonary capillary 
wedge pressure plus 50% of the pulmonary vein pulse pressure. Likewise, the diastolic 
pulmonary vein pressure is the wedge pressure less 50% of the pulse pressure. We assume a 2% 
pressure drop across the mitral, aortic, and tricuspid valves, giving us "QO,:l:. = 1.02	"PL,:l:. (12) "QO,<JP:. = 0.98	"iM,<JP:. (13) "Og,<JP:. = 1.02	`hO,<JP:.. (14) 
Furthermore, we assume that the pulse pressure in the vena cava ("Og,ii) is 5% of aortic pulse 
pressure, and thus the systolic pressure in the vena cava follows  "Og,:l:. = "Og,<JP:. + "Og,ii. (15) 
Stroke volume: Using the cardiac output (CO) and heart rate (HR) data we can calculate the 
stroke volume by 
SV = COHR/60 (16) 
Volume: Using a linear regression from Gutgesell and Rembold20, we calculate the end-diastolic 
left ventricular volume as #9<,QO = 93	BSA − 16, (17) 
where BSA denotes the body surface area calculated in Eq. (11). From Eq. (14) and (15), we can 
calculate the volume of the left ventricle at the end of systole by #9:,QO 	= 	#9<,QO	– 	SV. (18) 
Elastance: Nominal elastance parameter values are calculated from Eq. (2), (5), and (6) with the 
estimated compartmental blood volume (CBV) in compartment i as 
$J = "J,:l:. − ".H∗CBVJ − #<,J∗ , (19) 
where ".H is included for compartments housed in the thoracic cavity and #<,J is included for the 
left and right ventricle compartments. 
Resistances: Nominal resistance parameter values are calculated from Ohm’s Law using cardiac 
output (3ç) as our baseline flow and the corresponding pressure measurements by 
%J = "JK − "LM.CO . (20) 
For 10 unique data samples, we overwrote the systolic pulmonary artery pressure as this 
measurement was greater than or equal to the systolic right ventricle pressure. During systole, the 
pulmonary valve is open and blood flows from the right ventricle and into the pulmonary artery; 
however, due to the pressure gradient measured, blood would not flow since the valve would be 
closed. Therefore, we set "iP,:l:. = 0.95	"hO,:l:. (21) 
so that blood flows appropriately in these instances. All nominal parameter values and their units 
are listed in Table 2.  
Sensitivity Analysis: Sensitivity analysis calculates how the model output changes in response to 
perturbed parameter values. We define a sensitivity matrix é as  
éJ,è = êo((J, e)êeè eè (22) 
where o((J, e) represents the model output at the ë'th time point, and eè is the ì’th parameter, in 
log-transformed space. Due to the complexity of the model, é is difficult to calculate 
analytically, so similar to Pope et al.21we use finite differences to estimate é by 
éJ,è = o((J, e + ℎ+J) − o((J, e)ℎ  (23) 
where ℎ is chosen to reflect the accuracy of the model, and +J is the unit vector in the ë’th 
direction. To ensure that the error in sensitivities is on the same scale as the solver error in the 
model (ñ), it should follow that ℎ = √ñ. To approximate the influence that each parameter has 
on the model, we rank the sensitivities, %è, as the two-norm over each column of é 
%è = òôéJ,è0öJõú ù
ú0. (24) 
Parameter Subset Selection: In addition to being sensitive, it is important that parameters 
estimated are not correlated14. So, to determine a subset of parameters we used sensitivity-based 
covariance analysis to get a priori insight into potential correlation structure. For all sensitive 
parameters, we calculate the covariance matrix 
_Jè = 3JJ3èè3Jè ,			3 = (éûé),ú, (25) 
where é denotes the sensitivity matrix. This formulation is valid under the assumption that the 
variance is constant. The covariance matric _ is defined if éûé (also known as the Fisher 
information matrix) can be inverted necessitating the a priori removal of the any parameters that 
are perfectly correlated. Parameters for which _Jè > ü (here we let  ü = 0.9) are denoted 
correlated. Following the structured correlation method by Ottesen and Olufsen22, the covariance 
matrix is analyzed for all sensitive parameters. It is an iterative algorithm that removes the least 
sensitive parameter from a pair of correlated parameters. Parameters are removed sequentially 
until an uncorrelated subset is identified. Before the structured analysis discussed above, 
analytical knowledge is used to identify parameters that appear in structurally correlated 
combinations. All parameters that are removed from the subset are fixed at their nominal value. 
This analysis is local in nature as the sensitivity matrix is evaluated at nominal parameter values 
determined for each patient.  
Model Optimization and Parameter Identifiability: Next we use the cardiovascular system 
model to reproduce the clinical measures from the RHC procedure along with aortic blood 
pressure. Clinical measures of height, weight and gender are used to estimate total blood volume 
(Eq. 10) and heart rate is used to drive the model (Eq. 1) while the remaining measures are 
matched to the output of the model simulation (light gray shaded measures in Table 1). For each 
patient, we estimate a subset of parameters e∗, that minimize the least squares error 
† = °.°, (26) 
where ° = {°¢, °£, °§, °•} is a residual vector of entries ¶J, where 1 ≤ ë ≤ 8 and 
¶ßú = 1√8maxF"ß((J)G − "ß,:l:.<"ß,:l:.< ,					© = {]™, `], ¶^} 
¶ß0 = 1√8minF"ß((J)G − "ß,<JP:.<"ß,<JP:.< , © = {]™, `], ¶^} 
¶ig¨{ = 1√8
∫ "ig¨((J)/Æ/Ø N(30 − 3ú − "ig¨<"ig¨< ,				 
¶:l:∞ = 1√8
∫ !:l:((J)/Æ/Ø N(30 − 3ú − 3ç<3ç< , 
where quantities with superscript N refer to data. Capillary wedge pressure ("ig¨) and cardiac 
output (!:l:) are measured as average values therefore, simulated predictions are averaged over 
the cardiac cycle before being compared to data. Here, 3ú and 30 refer to the beginning and end 
of the cardiac cycle, respectively. Given that quantities minimized are of different units, each 
residual function is divided by a characteristic value for the quantity. 
Once we have identified patient-specific models for each set of RHC and aortic blood pressure 
data we can further investigate identifiability and correlation around a representative set of 
optimized parameters from one patient for each of the two parameter subsets. To overcome the 
limitation of the local approach, similar to Marquis et al.14 we applied the Delay Rejection 
Adaptative Metropolis (DRAM)23, a Metropolis Hastings type Markov Chain Monte-Carlo 
(MCMC) algorithm to verify that our deterministic results are reasonable. For this analysis we 
used a normal joint a priori distribution with the mean obtained from the point estimate obtained 
using the Levenberg-Marquardt gradient based optimization method24.  
 
Results  
Sensitivity, subset selection and comparison of model results: In this study, we selected two 
subsets of parameters to analyze. The first is based on known parameters of physiological 
interest; whereas the second is formed to include identifiable parameters determined from local 
sensitivity and structured correlation analysis. Figure 3 presents the normalized ranked parameter 
sensitivities for a characteristic data set and the two parameter subsets chosen for this study. %PO, 3,	and	%m.	are not included in the subset as their ranked sensitivity value is less than 0.01. 
These parameters were fixed at their nominal values and not included in correlation analysis. For 
the remaining parameters, we used the structured correlation algorithm mentioned22 to determine 
an identifiable parameter set.  For all patients, we used a correlation threshold of ü = 	0.9. This 
analysis revealed that the sensitivity-based identifiable parameter subset:  e≤ = {ChO, CQO, %:l:, $iM, %iMQ, $iP, %iO, $PL} 
is identifiable. Results shown in Figure 4 for patient 233, are obtained estimating the sensitivity-
based identifiable subset  e≤, while minimizing the least square error Eqn. (26). Optimized 
parameter values  e≤Li. are given in Table 3.  
Similar results are shown in Figure 5 for model optimization to data for patient 233 using the 
physiologically-based parameter subset e≥ = {$hO, $QO, %:l:, $iM, %iMQ, $iP, %iO, $PL, #<,QO}	
with the optimized parameter values given in Table 3. Nominal parameter values are calculated 
as in Table 2 using data given in Table 1 for each patient. A table with optimized parameter 
values for the initial RHC dataset for each patient is given in the supplementary material (Table 
S2).  Note that the two subsets e≤ and e≥ have 6 parameters in common, egLm ={$iM, $iMQ,$iP, $PL, %:l:, %iMQ, %iO}. From a physiological point of view, the systolic elastances 
of the left and right ventricles ($QO and $hO) are easier to interpret than the parameters defining 
diastolic filling (CQO and ChO) and therefore they are included in the physiological subset e≥. 
However, correlation analysis revealed that parameters $hO & ChO and $QO & CQO are correlated 
and that the elastance parameters are less sensitive. Therefore the identifiable parameter set e≤ 
includes CQO, ChO and fixes$QO and $hO at their nominal values. Next, we observe #<,QO is strongly 
correlated with $hO, $QO, %:l:, $iM,	and	$PL.	Removing #<,QO from the subset, fixing it at its 
nominal value, eliminated correlations within the remaining subset.  
When we optimize e≤ and e≥, the residual least squares cost is on the same order of magnitude 
(1.94 × 10,µ and 3.55 × 10,µ, respectively for patient 233). The physiological-based 
parameter subset, e≥, for patient 233 gives estimations of left and right ventricular volume that 
differ significantly in magnitude (Figure 5f) while in the sensitivity-based identifiable parameter 
subset, e≤, optimized model the systolic and diastolic volumes are similar in magnitude (Figure 
4f). Systolic and diastolic volumes for the right and left ventricles are expected to be similar in a 
normal cardiovascular state25 which is in line with the sensitivity-based identifiable parameter 
subset optimization predictions, however no studies have been performed quantifying ventricular 
volumes in post-transplant hearts. 
Parameter identifiability: We performed a delayed rejection adaptive metropolis (DRAM) 
analysis to confirm the degree of identifiability for each of our two parameter subsets and to 
further uncover which parameters in the subset are correlated. For each of the two parameter 
subsets  e≤ and e≥ we set up normal joint a priori distribution with the mean obtained from the 
point estimates discussed above. The DRAM algorithm was run with 100,000 sample points. To 
ensure that our solutions converge to steady state prior to calculating posterior distributions and 
correlations we removed the burn-in set to 10,000 sample points. Figure 6 shows that for both 
parameter subsets the chains have converged (top two panels). The bottom panels in Figure 6 
show the posterior distributions for each parameter in both subsets. For the physiological 
subset e≥,  we observed that the parameter	#<,QO for the dead space volume in the left ventricle has 
an identical distribution as the parameter $QO, the elastance of the left ventricle. This suggest that 
the parameters are correlated with a single valued relation; this is equivalent to saying their 
Pearson correlation is +1. This correlation is confirmed in Figure 7 depicting pairwise 
distributions. Therefore, fixing one of the two parameters may improve the DRAM results of the 
physiologically-based parameter subset. Posterior and pairwise distributions for the sensitivity-
based identifiable parameter subset confirm local observations that all parameters are 
independent. 
Longitudinal analysis: Using the cardiovascular systems model with the sensitivity-based 
identifiable parameter subset, RHC measures were analyzed to represent cardiovascular 
functional changes during recovery in five of the ten patients where multiple RHC measures 
were available. Figure 8 shows the changes in cardiovascular states as indicated from simulated 
left and right ventricular pressure-volume loops for two patients (patient 266 and 558). This 
figure shows a consistent reduction in right and left ventricular pressure during recovery in 
patient 266 that are not seen with patient 558. In both patients, systolic volumes in both 
ventricles increases during recovery with diastolic volumes remaining relatively constant. This 
representation of cardiovascular function cannot be obtained from the RHC measures without the 
use of the computational analysis. As shown in Figure 9, we can also track individual parameters 
longitudinally, where the values of the sensitivity-based identifiable parameter subset are plotted 
longitudinally for patients 266 and 558. Pressure-volume loops and parameter trends for the 
remaining three patients are given in the supplemental material (Figures S1 and S2.)   
Discussion 
In this study, we have developed an approach where cardiovascular system model parameters 
sensitive to the clinically measured cardiovascular variables are selected, then estimated to 
closely represent RHC and aortic blood pressure data, and subsequently used to predict 
cardiovascular function in heart transplant patients. We use this approach to make longitudinal 
predictions of cardiovascular function, elucidating changes over time, in an effort to provide 
insight into trends that translate to improved treatment after heart transplant. In the process, we 
showed that selecting an identifiable parameter subset is of vital importance to confidently 
determine mechanistic model parameters. These patient-specific models of cardiovascular 
function are used to predict ventricular elastance in end systole, diastolic filling function, aortic 
stiffness, total peripheral resistance, and generate left and right ventricular pressure-volume 
loops, each of which is not directly measurable in the clinic. 
Model parameter subset selection. The model selected for this study was developed to estimate 
the systolic and diastolic pressures, average pulmonary capillary wedge pressure and cardiac 
output obtained from EHR records. Using the Smith et al.12 cardiovascular systems model as the 
reference model we carefully selected components that could be informed by the available data. 
The major components omitted were ventricular-ventricular interaction and inertance at each of 
the heart valves. If more detailed pressure time courses were available, it is possible a more 
complex cardiovascular system model could be implemented. After determining the model 
structure, parameters of physiologic interest were selected for optimization to data based on 
knowledge of the cardiovascular system and what may be important to quantify for evaluation of 
cardiovascular function in post-transplanted hearts. The problem with this approach is that there 
is no guarantee that the RHC, aortic pressure, height, weight and gender data obtained in each 
patient has enough informational content to identify these parameters of physiological interest. 
Therefore, we used a more objective approach, leveraging sensitivity analysis around nominal 
fits to the data, to select the parameters in the reduced model that can be confidently predicted 
with the given data. 
The physiologically-based parameter subset included resistances of the systemic vasculature 
(Rsys), pulmonary vasculature (Rpul) and pulmonary valve (Rpv) along with elastances of the left 
ventricle (Elv), right ventricle (Erv), pulmonary vein ($iM), pulmonary artery (Epa), and aorta (Eao) 
and the dead space volume in the left ventricle (#<,QO) as shown by the red squares in Figure 3. 
The sensitivity-based subset selection approach omitted the dead space volume parameter in the 
left ventricle and identified the correlation between the elastance parameters in the left and right 
ventricles and the more sensitive diastolic filling exponents in the left and right ventricle, CQO and ChOas shown by the blue circles in Figure 3. This result suggests that quantifying the parameters 
determining diastolic filling in the left and right ventricle will have more ability to discriminate 
underlying cardiovascular function than the quantifying the parameters determining systolic 
contraction. The sensitivity-based approach did not identify the pulmonary valve resistance (%iO) 
as having high sensitivity, however this was added to the sensitivity-based identifiable subset 
since we had data for right ventricular and pulmonary artery pressure across the valve along with 
cardiac output. This parameter should be able to be uniquely identified from the data alone 
however it was included as an adjustable parameter to provide maximum flexibility in matching 
the two pressures and cardiac output simultaneously.  
A physiologically-based approach for selecting model parameters to optimize captures the 
intuitive reasons for parameters of interest. However, this approach does not identify correlation 
between parameters and therefore can produce a subset which is unidentifiable given our 
experimental data. In comparison, the sensitivity-based approach selected a subset with six 
parameters in common with the physiologically-based parameter subset objectively confirming a 
majority of the parameters selected physiologically while considering the ability of the data to 
inform the selected subset. If parameters that are non-identifiable in this current study are 
deemed to be important for the evaluation of heart transplant recovery the analysis methodology 
used here can be employed to find out clinical measures that would need to be obtained to be 
uniquely identified. For example, if the quantification of VVI is thought to be an important 
prognostic metric we could analyze the more complex Smith et al. model which includes this 
effect to find out what set of clinical measures could be used to reliably identify the septal wall 
stiffness that is the key governing parameter governing VVI.  
Model optimization using both selected parameter subsets. Model optimization using both the 
sensitivity-based identifiable and the physiologically-based parameter subsets were able to fit the 
RHC data and aortic pressure measures with approximately the same small relative error as can 
be seen comparing the RHC measures (dashed lines) and simulated pressure and cardiac output 
time courses (solid lines) in panels a, b and c of Figures 4 and 5, respectively. Differences in the 
model optimizations appear only in the predicted volumes of left and right ventricle where the 
physiologically-based subset optimization predict smaller right ventricular volumes and larger 
left ventricular volumes as shown in Figures 4e,f and 5e,f. The sensitivity-based identifiable 
parameter subset model parameterizations across all patients in this study consistently results in 
closely matched left and right ventricular volume ranges. It has been observed in normal hearts 
that the ventricular volumes are typically similar between right and left sides of the heart25-27 
with the right ventricular volume on the order of 5-10% smaller than the left ventricular volumes. 
However, in these same studies right ventricular volumes can be as much as 48% smaller or 68% 
larger depending on the gender considered, the measurement modality and the method used to 
calculate the volume from the images obtained. No similar studies have been conducted for 
ventricular volumes in patients with cardiac hypertrophy, with pulmonary hypertension or after 
heart transplantation. 
Confidence in the use of the sensitivity-based identifiable parameter subset is further bolstered 
by the results of the DRAM analysis as shown in Figure 6. In the neighborhood of the model 
optimization to patient 233 data, parameter distributions for all parameters in the selected 
sensitivity-based identifiable subset show a narrow Gaussian distribution whereas the parameter 
distributions for two parameters in the physiologically-based parameter subset, the pairwise 
distributions for $QO and #<,QO, are clearly correlated and their distributions are proportional over 
the range of each parameter value. 
Optimized parameter relationship to CV function and subsequent model predictions. 
Optimization of selected model parameters tell us about the underlying function that represents 
the upper level phenotype quantified clinically in this case with RHC and aortic blood pressure 
measures. From the optimized models of the initial datasets from the ten patients shown in Table 
4 we observe that two patients (#60 and 558) have a relatively low left ventricle diastolic filling 
values (0.0225 and 0.0297, respectively). These two patients also have the largest predicted 
stroke volume (~100 mL and ~110 mL, respectively) using each of their patient-specific models. 
The stroke volume is determined by the measured heart rate and cardiac output but manifests 
itself in this parameter which prescribes the diastolic pressure volume relationship of the left 
ventricle.  
Since this model is nonlinear there is not a one to one relationship between each model 
parameter and the upper level clinical measures, however, the power of this approach is that with 
a model tailored to describe an individual patient’s cardiovascular system function we can now 
make predictions of function that are not able to be easily measured. One example of this is the 
left and right ventricular pressure volume loops. These pressure volume (PV) loops can be used 
to more accurately determine functional metrics such as the left ventricular end diastolic and end 
systolic pressure volume relationships and both right and left ventricular work and power which 
show important changes from health to dysfunction. Even though these are important diagnostic 
metrics, simultaneous measurement of left ventricular volume and pressure without using an 
invasive indwelling catheter in the left heart is impossible in the clinic therefore they are rarely 
obtained. Employing our model analysis with the minimally invasive RHC measurements 
enables us to predict both right and left ventricular volumes while fitting the cardiovascular 
pressures in a patient-specific manner, producing these PV loops. In Figures 4d,e and f we see 
the predicted left and right ventricular pressure, volumes and pressure volume loops for patient 
233. The relatively high left ventricular diastolic filling pressure shown results from the 
pulmonary hypertension of the right side and the left ventricular ejection fraction of about 48% 
are both metrics that in a recently transplanted heart warrant close monitoring. 
Longitudinal analysis of cardiovascular function. In order to provide additional tracking of 
cardiovascular function we have performed analysis on RHCs performed at several post-
transplant time points in patients 266, 363, 456, 558 and 572. For patient 266, parameter and left 
and right PV loop trends as a function of time shown in Figure 6 shows a reduction in right 
ventricular pressure along with an increase in end systolic volume over seven timepoints 
spanning 11 months post-transplant. It is known that pulmonary hypertension (>25-30 mmHg) is 
often observed post-transplant with a trend to normal right-side pressures (~20 mmHg) in a 
successful recovery28. The RHC data alone shows this, however here we observe that in this 
patient over this time span, the ejection fraction decreases by ~60%, the left ventricular end 
diastolic pressure decreases from about 10 to 5 mmHg, the aortic elastance decreases (reduction 
in stiffness) by ~65% and the systemic resistance increases by ~10%. These characteristics 
describe the constellation of concurrent changes that can be quantified in not only the 
transplanted heart but the pulmonary and systemic cardiovascular system over time. While the 
predicted reduction in ejection fraction points to reduced cardiovascular function in this patient 
this is likely due to the fact that volumes are not constrained by any clinical measures in this 
study. The inclusion of periodic echocardiograms along with the heart rate close to the time of 
each RHC could be used as another set of measures to bound the left ventricular end diastolic 
and end systolic volumes in the optimized models. Patient 558 on the other hand shows a slight 
increase in right ventricular pressure over the 7 timepoints spanning 5 months. For this patient, 
the model predicts a consistent end diastolic pressure of about 10 mmHg, an increase in aortic 
elastance (stiffening) by ~64%, an increase in systemic resistance by ~69% as well distinct 
arterial hypertension rising to ~175 mmHg as shown in the aortic pressure measurements. These 
results suggest a less successful recovery for patient 558 than for patient 266. 
Conclusion 
In this study we have presented a workflow pushing model design and sensitivity analysis prior 
to model optimization to data to aid in selecting the model parameters that are most likely to be 
informed by the clinical measures. We have used clinical RHC and aortic blood pressure data 
measured from patients shortly after heart transplantation to determine an identifiable parameter 
subset obtained objectively and contrasted it to a subset that was selected based on physiological 
features of interest. Optimization based on both selected parameter subsets replicated the clinical 
data equivalently however a single insensitive parameter in the physiologically-based subset 
decreased the confidence in the identification of the remaining parameters and the predictions 
made by the physiologically-based subset optimized model. To illustrate the potential to track 
cardiovascular function over time, model optimizations were performed on multiple RHC and 
aortic pressure measurements for several patients and the trends in model parameters were 
shown. This approach has the ability to provide clinicians with previously unobtainable 
functional information, such as left and right ventricular pressure volume loops and systemic 
vascular resistance, from routinely obtained RHC measures. This additional functional 
information is not only valuable in the assessment of post-heart transplant recovery but in other 
cases of cardiovascular dysfunction where RHC measurements are made such as heart failure 
both with reduced and preserved ejection fraction or pulmonary hypertension. 
  
Bibliography 
1. Bhatia SJS, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Disesa VJ, Young PJ, 
Mudge GH and Sutton MGS. Time course of resolution of pulmonary hypertension and right 
ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987;76:819-
826. 
2. Greenberg ML, Uretsky BF, Reddy PS, Bernstein RL, Griffith BP, Hardesty RL, Thompson 
ME and Bahnson HT. Long-term hemodynamic follow-up of cardiac transplant patients 
treated with cyclosporine and prednisone. Circulation. 1985;71:487-494. 
3. Goland S, Czer LSC, Kass RM, De Robertis MA, Mirocha J, Coleman B, Capelli C, Raissi S, 
Cheng W, Fontana G and Trento A. Pre-existing pulmonary hypertension in patients with 
end-stage heart failure: Impact on clinical outcome and hemodynamic follow-up after 
orthotopic heart transplantation. J Heart Lung Transplant. 2007;26:312-318. 
4. Young JB, Leon CA, Short HD, 3rd, Noon GP, Lawrence EC, Whisennand HH, Pratt CM, 
Goodman DA, Weilbaecher D, Quinones MA and et al. Evolution of hemodynamics after 
orthotopic heart and heart-lung transplantation: early restrictive patterns persisting in occult 
fashion. J Heart Transplant. 1987;6:34-43. 
5. Stobierska-Dzierzek B, Awad H and Michler RE. The evolving management of acute right-
sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 2001;38:923-931. 
6. Armitage JM, Hardesty RL and Griffith BP. Prostaglandin E1: an effective Treatment of right 
heart failure after orthotopic heart transplantation. Journal of Heart Transplantation. 
1987;6:348-351. 
7. Dandel M, Hummel M, Muller J, Wellnhofer E, Meyer R, Solowjowa N, Ewert R and Hetzer 
R. Reliability of tissue Doppler wall motion monitoring after heart transplantation for 
replacement of invasive routine screenings by optimally timed cardiac biopsies and 
catheterizations. Circulation. 2001;104:I184-I191. 
8. Sundereswaran L, Nagueh SF, Vardan S, Middleton KJ, Zoghbi WA, Quinones MA and 
Torre-Amione G. Estimation of left and right ventricular filling pressures after heart 
transplantation by tissue Doppler imaging. Am J Cardiol. 1998;82:352-357. 
9. Marie PY, Angioi M, Carteaux JP, Escanye JM, Mattei S, Tzvetanov K, Claudon O, Hassan 
N, Danchin N, Karcher G, Bertrand A, Walker PM and Villemot JP. Detection and prediction 
of acute heart transplant rejection with the myocardial T-2 determination provided by a 
black-blood magnetic resonance imaging sequence. J Am Coll Cardiol. 2001;37:825-831. 
10. Sun JP, Abdalla IA, Asher CR, Greenberg NL, Popovic ZB, Taylor DO, Starling RC, 
Thomas JD and Garcia MJ. Non-invasive evaluation of orthotopic heart transplant rejection 
by echocardiography. J Heart Lung Transplant. 2005;24:160-165. 
11. Beard DA, Pettersen KH, Carlson BE, Omholt SW and Bugenhagen SM. A computational 
analysis of the long-term regulation of arterial pressure. F1000Res. 2013;2:208. 
12. Smith BW, Chase JG, Nokes RI, Shaw GM and Wake G. Minimal haemodynamic system 
model including ventricular interaction and valve dynamics. Med Eng Phys. 2004;26:131-
139. 
13. Lumens J, Delhaas T, Kirn B and Arts T. Three-wall segment (TriSeg) model describing 
mechanics and hemodynamics of ventricular interaction. Ann Biomed Eng. 2009;37:2234-
2255. 
14. Marquis AD, Arnold A, Dean-Bernhoft C, Carlson BE and Olufsen MS. Practical 
identifiability and uncertainty quantification of a pulsatile cardiovascular model. Math 
Biosci. 2018;304:9-24. 
15. Nadler SB, Hidalgo JU and Bloch T. Prediction of blood volume in normal human adults. 
Surgery. 1962;51:224-232. 
16. Du Bois D and Du Bois EF. A formula to estimate the approximate surface area if height and 
weight be known. Arch Intern Med. 1916;17:863-871. 
17. Trippodo NC. Total circulatory capacity in the rat. Effects of epinephrine and vasopressin on 
compliance and unstressed volume. Circ Res. 1981;49:923-931. 
18. Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 
2008;108:735-748. 
19. Beneken JEW. A Physical Approach to Hemodynamic Aspects of the Human Cardiovascular 
System In Physical Bases of Circulatory Transport: Regulation and Exchange Physical Bases 
of Circulatory Transport Philadelphia, PA, USA: W.B. Saunders; 1967: 1-45. 
20. Gutgesell HP and Rembold CM. Growth of the human heart relative to body surface area. 
Am J Cardiol. 1990;65:662-668. 
21. Pope SR, Ellwein LM, Zapata CL, Novak V, Kelley CT and Olufsen MS. Estimation and 
identification of parameters in a lumped cerebrovascular model. Math Biosci Eng. 2009;6:93-
115. 
22. Olufsen MS and Ottesen JT. A practical approach to parameter estimation applied to model 
predicting heart rate regulation. J Math Biol. 2013;67:39-68. 
23. Haario H, Laine M, Mira A and Saksman E. DRAM: efficient adaptive MCMC. Stat 
Comput. 2006;16:339-354. 
24. Kelley CT. Iterative Methods for Optimization: Society of Industrial and Applied 
Mathematics; 1999. 
25. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP and Sivananthan MU. Normal human left 
and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state 
free precession imaging sequences. J Magn Reson Imaging. 2003;17:323-329. 
26. Hergan K, Schuster A, Fruehwald J, Mair M, Burger R and Topker M. Comparison of left 
and right ventricular volume measurement using the Simpson's method and the area length 
method. Eur J Radiol. 2008;65:270-278. 
27. Hudsmith LE, Petersen SE, Francis JM, Robson MD and Neubauer S. Normal human left 
and right ventricular and left atrial dimensions using steady state free precession magnetic 
resonance imaging. J Cardiovasc Magn Reson. 2005;7:775-782. 
28. Delgado JF, Gomez-Sanchez MA, de la Calzada CS, Sanchez V, Escribano P, Hernandez-
Afonso J, Tello R, de la Camara AG, Rodriguez E and Rufilanchas JJ. Impact of mild 
pulmonary hypertension on mortality and pulmonary artery pressure profile after heart 
transplantation. J Heart Lung Transplant. 2001;20:942-948. 
29. Williams ND, Wind-Willassen O, Wright AA, Program R, Mehlsen J, Ottesen JT and 
Olufsen MS. Patient-specific modelling of head-up tilt. Math Med Biol. 2014;31:365-392. 
30. Smith BW, Andreassen S, Shaw GM, Jensen PL, Rees SE and Chase JG. Simulation of 
cardiovascular system diseases by including the automatic nervous system into a minimal 
model. Comput Methods Programs Biomed. 2007;86:153-160. 
31. Nielsens H. CellML version of the cardiovascular systems model presented in Smith et al. 
Med Eng Phys 28:131-139, 2004. Published in 2010 and available at: 
https://models.physiomeproject.org/workspace/smith_chase_nokes_shaw_wake_2004/file/f7
b732c9707abdba5a55d471c49baf7dee92b036/smith_chase_nokes_shaw_wake_2004.cellml 
 
  
Appendix A 
Model Equations 
The complete list of differential equations representing the rate of change of volume of the 
compartments in this study are as follows: N#QON( = !m. − !PO	N#PLN( = !PO − $PL#PL − $Og#Og%:l: 	N#OgN( = $PL#PL − $Og#Og%:l: − !.g	N#hON( = !.g − !iO	N#iPN( = !iO − $iP#iP − $iM#iM%iMQ 	N#iMN( = $iP#iP − $iM#iM%iMQ − !m. 
where 
!m. = ∫F$iM#iM + ".HG − "QO%m. 			if	valve	open	F`iM > `QOG																		0																							otherwise	(valve	closed) 		
!PO = ∫"QO − $PL#PL%PO 				if	valve	open	(`QO > `PL)											0														otherwise	(valve	closed) 			
!.g = ∫$Og#Og − "hO%.g 				if	valve	open	(`Og > `hO)										0																otherwise	(valve	closed) 	
!iO = ∫"hO − ($iP#iP + ".H)%iO 			if	valve	open	F`hO > `iPG																0																							otherwise	(valve	closed) 		 
and 
"QO = $(() ª$QOF#QO − #<,QOGº + ªF1 − $(()G"=,QOF+>ΩæF?Ωæ,?B,ΩæG − 1Gº + ".H,	"hO = $(() ª$hOF#hO − #<,hOGº + ªF1 − $(()G"=,hOF+>øæF?øæ,?B,øæG − 1Gº + ".H, $(() = 	 +,-(.,/)0	.		
  
Tables 
Table 1. Right heart catheter measurements extracted from the clinical data repository at the University of 
Washington Medicine Regional Heart Center. 
Patient "hO 
systole 
"hO 
diastole 
"iP 
systole 
"iP 
diastole 
"ig¨ 
average 
"PL 
systole 
"PL 
diastole 
Cardiac 
output 
HR Weight 
(kg) 
Height 
(cm) 
Sex 
060 36 2 36* 14 16 132 79 4.9 69 61.5 180 M 
066 28 1 26 13 8 134 79 6.6 81 120.4 194 M 
233 40 4 35 19 19 149 83 7.3 83 96.1 172 F 
266 37 10 34 14 11 154 81 6.39 90 75 169 M 
363 22 1 21 13 7 119 87 3.6 92 75.3 162 M 
456 44 4 35 13 16 104 67 5.2 90 77.8 170 M 
558 31 3 32* 15 14 114 49 10.0 90 100.6 170 F 
572 31 5 30 12 12 116 66 5.4 100 82.4 180 M 
794 38 6 39* 17 21 98 57 4.9 84 44 174 F 
839 25 1 18 9 7 135 84 5.9 91 83 170 M 
* indicates pulmonary artery pressure that was reduced to be less than that of the pressure in the right ventricle only 
when calculating nominal parameter values. 
Table 2. Equations for the calculation of nominal parameter values used in this study. 
 Parameter Units Equation Mean ± std Reference/ 
Comment 
Heart 
Parameters 
 
2 ¡,ú HR 91 ± 13 Data 3 ¡ "+¶ë™N 2⁄  0.34 ± 0.05 Data 
Left 
Ventricle 
$9:,QO mmHgmL  "QO,:l:. + ".H#QO,m − #<,QOƒ	 1.54 ± 0.4 * #<,QO mL  10 Williams (2014)29 "=,QO mmHg  0.125 ** CQO mL,ú  0.03 ** #=,QO mL  12 ** 
Right 
Ventricle 
$9:,hO mmHgmL  "hO,:l:. + ".H#hO,m − #<,hOƒ 0.43 ± 0.2 * #<,hO mL  9 ** "=,hO mmHg  0.25 ** ChO mL,ú  0.025 ** #=,hO mL  10.8 ** 
Pulmonary 
Vasculature  
$9:,iP mmHgmL  "iP,:l:. + ".H32#iP  0.29 ± 0.09 * $9:,iM mmHgmL  "iM,:l:. + ".H32#iM  0.012 ± 0.006 * %iMQ mmHg	⋅	smL  "iP,:l:. − "iM,<JP:.CO 	 0.20 ± 0.06 Ohm’s Law/Data ".H mmHg  −4 Smith (2007)30 
Systemic 
Vasculature 
$9:,PL mmHgmL  "PL,:l:.32#PL  0.9 ± 0.1 * $9:,Og mmHgmL  "Og,:l:.32#Og  0.02 ± 0.01 * %:l: mmHg	⋅	smL  "PL,:l:. − "Og,<JP:.CO  1.31 ± 0.32 Ohm’s Law/Data 
Heart 
Valves 
%m. mmHg	⋅	smL  "iM,<JP:. − "QO,<JP:.CO  0.0022 ± 0.0009 Ohm’s Law/Data %PO mmHg	⋅	smL  "QO,:l:. − "PL,:l:.CO  0.0272 ± 0.0064 Ohm’s Law/Data %.g mmHg	⋅	smL  "Og,<JP:. − "hO,<JP:.CO  0.0010 ± 0.0007 Ohm’s Law/Data %iO mmHg	⋅	smL  "hO,:l:. − "iP,:l:.CO  0.0322 ± 0.0264 Ohm’s Law/Data 
CO stands for cardiac output, CBV for circulating blood volume, P for pressure and HR for heart rate. Subscript lv 
stands for left ventricle, rv for right ventricle, th for thoracic chamber, lvf for left ventricular free wall, rvf for right 
ventricular free wall, syst for systole, diast for diastole, m for mean, d for dead space, pa for pulmonary artery, pu 
for pulmonary veins, ao for aorta and vc for vena cava. Entries noted with * are computed by inverting the model 
equations using available data as described in methods. Entries noted with ** are set by hand fitting our normal CV 
function model output to the Smith model output using the CellML version values of the Smith model31 as a guide. 
 
Table 3. Nominal and optimized parameter values for patient 233 using the sensitivity-based identifiable 
parameter subset	Fe≤G and the physiological-based parameter subset	Fe≥G 
Parameter Units Nominal 
Optimized 
SBIP, e≤ PBP, e≥ CQO 1 mL⁄  0.03 0.0313 --- ChO  1 mL⁄  0.025 0.0228 --- $9:,QO mmHg mL⁄  1.942 --- 1.748 #<,QO  mL 10 --- 8.293 $9:,hO  mmHg mL⁄  0.568 --- 0.694 $9:,iP  mmHg mL⁄  0.408 0.2751 0.278 $9:,iM mmHg mL⁄  0.0203 0.0275 0.0273 %iMQ  mmHg	∙	s mL⁄  0.147 0.0502 0.0499 $9:,PL mmHg mL⁄  1.067 0.949 0.946 %:l: mmHg	∙	s mL⁄  1.185 0.898 0.898 %iO  mmHg	∙	s mL⁄  0.0409 0.0103 0.0105 
 
  
Table 4. Optimized parameter values for first post-transplant RHC dataset from each patient using the 
sensitivity-based identifiable parameter subset	Fe≤G 
Parameter Units 
Patient Number 
60 66 233 266 363 456 558 572 794 839 CQO mL,ú 0.0371 0.0225 0.0313 0.0357 0.0366 0.0356 0.0297 0.0310 0.0473 0.0317 ChO mL,ú 0.0274 0.0153 0.0228 0.0321 0.0304 0.0288 0.0208 0.0245 0.0392 0.0232 $9:,iP mmHgmL  1.235 0.204 0.275 0.435 0.281 0.878 0.196 0.586 1.801 0.198 $9:,iM mmHgmL  0.0213 0.0089 0.0275 0.019 0.0244 0.022 0.0204 0.0168 0.0409 0.0118 %iMQ mmHg	⋅	smL  0.04 0.093 0.0502 0.103 0.167 0.0613 0.0408 0.0698 0.0365 0.0538 $9:,PL mmHgmL  0.897 0.820 0.949 1.313 0.960 0.784 0.783 1.167 0.888 0.963 %:l: mmHg	⋅	smL  1.235 0.941 0.898 0.976 1.211 0.916 0.453 0.930 0.850 1.084 %iO mmHg	⋅	smL  0.0037 0.0048 0.0103 0.0103 0.007 0.0238 0.0026 0.0036 0.0042 0.0167 
 
 
 
 
  
Figures 
 
Figure 1. Retrospective approach taking EHR data, applying it to a mechanistic models of the closed loop 
cardiovascular system to generate model versions representing cardiovascular function of each patient (or 
patient at different times) which can then be used to understand differences between the outcomes across 
populations of patients.   
  
Figure 2. Schematic of closed loop cardiovascular system models used in this study. In the model by 
Smith et al. left and right ventricles interact by accounting for the dynamic pressure difference across the 
septal wall. In the reduced version of the model used in this study, ventricular-ventricular interaction 
along with inertance of the blood moving through the four heart valves is removed. 
  
 
Figure 3. Ranked sensitivities for all parameters in the reduced model around nominal values for a single 
patient record. Blue squares indicate the parameters selected by identifiability after sensitive parameters 
were also assessed for structural correlation while the red circles indicate those thought to be interesting 
based on their physiological meaning.  
  
 
Figure 4. Model predictions for subject 233 with optimized sensitivity-based identifiable parameter subset 
values, θ≤. Left ventricle, pulmonary vein, & aorta (a) and right ventricle, pulmonary artery, & vena cava 
(b) comparison of computed results (solid lines) and data (broken lines). d) comparison of left and right 
ventricular pressure. e) computed left and right ventricular volume (no data available).  f) Left and right 
ventricular pressure volume loop (PV loop) with calculated stroke work. 
  
 
Figure 5. Model predictions for subject 233 with optimized physiologically-based parameter subset 
values, θ≥. Left ventricle, pulmonary vein, & aorta (a) and right ventricle, pulmonary artery, & vena cava 
(b) comparison of computed results (solid lines) and data (broken lines). d) comparison of left and right 
ventricular pressure. e) computed left and right ventricular volume (no data available).  f) Left and right 
ventricular pressure volume loop (PV loop) with calculated stroke work 
  
 
Figure 6. DRAM-based convergence chains (upper two panels) and parameter distributions (lower two 
panels) at optimized parameter values for patient 233 using the sensitivity-based identifiable (left column 
panels) and physiologically-based (right column panels) parameter subsets. 
  
 
Figure 7. Pairwise distribution of parameters for each parameter subset to check for correlation. In the 
physiologically-based parameter subset, Elv and Vlv,d are seen to be correlated since the relationship 
between the two distributions can be clearly seen. Pairwise parameters showing no correlation form a 
large cloud of points indicating no distinct relationship exists between the two distributions. 
  
 
Figure 8. Simulated pressure-volume loops over time for patients 266 and 558 predicting dramatically 
different progression during recovery. Chronological progression earliest to latest by color is magenta, 
red, yellow, green, aqua, blue and black. Even in the case that an echocardiogram is performed in addition 
to an RHC a patient the pressure and volume are not obtained simultaneously therefore these pressure 
volume loops cannot be generated except by simulation as proposed here. 
  
 
Figure 9. Longitudinal parameter trends for optimized parameters from the sensitivity-based identifiable 
parameter subset for patients 266 and 558. 
Supplemental Material for: 
Deep phenotyping of cardiac function in heart transplant using 
cardiovascular systems models 
By: N. Payton Woodall, K. Graham Kim, Amanda L. Colunga, John H. Gennari, 
Mette S. Olufsen and Brian E. Carlson 
  
Table S1. Right heart catheter measurements extracted from the clinical data repository at the University 
of Washington Medicine Regional Heart Center. 
Patient !"# 
systole 
!"# 
diastole 
!$% 
systole 
!$% 
diastole 
!$&' 
average 
!%( 
systole 
!%( 
diastole 
Cardiac 
output 
HR Weight 
(kg) 
Height 
(cm) 
Sex 
060 36 2 36* 14 16 132 79 4.9 69 61.5 180 M 
066 28 1 26 13 8 134 79 6.6 81 120.4 194 M 
233 40 4 35 19 19 149 83 7.3 83 96.1 172 F 
266(3) 37 10 34 14 11 154 81 6.39 90 75 169 M 
266(8) 30 6 27 10 9 121 75 6.09 94 71.4 169 M 
266(9) 29 9 30* 13 12 115 82 6.02 96 72.8 169 M 
266(10) 27 8 25 10 9 112 69 6.17 92 73.3 169 M 
266(11) 23 5 26* 10 8 106 77 4.69 94 74.9 169 M 
266(14) 27 9 28* 12 11 119 81 4.55 101 79 169 M 
266(15) 22 5 22* 8 7 107 76 4.6 102 75 169 M 
363(2) 30 7 30* 20 12 108 78 4.2 109 80 162 M 
363(5) 22 1 21 13 7 119 87 3.6 92 75.3 162 M 
363(6) 25 2 25* 17 10 113 73 2.6 108 79 162 M 
363(10) 26 1 24 12 7 107 85 3.7 119 78.9 163 M 
456(1) 44 4 35 13 16 104 67 5.2 90 77.8 170 M 
456(2) 42 4 36 14 15 122 75 4.4 86 77.8 170 M 
456(3) 39 2 33 14 13 128 88 4.7 93 75 170 M 
456(6) 23 5 24* 13 6 130 79 4.4 108 77.8 170 M 
456(7) 37 11 33 18 15 118 78 5.0 93 77.8 170 M 
456(8) 34 12 31 18 14 133 75 5.3 103 73 170 M 
456(9) 30 4 24 13 9 110 74 4.9 99 77.8 170 M 
456(10) 28 1 24 9 6 99 63 4.4 100 74.4 170 M 
558(2) 31 3 32* 15 14 114 49 10.0 90 100.6 170 F 
558(5) 38 7 33 12 15 124 77 6.7 63 100.6 170 F 
558(6) 34 5 33 14 18 144 85 6.7 71 101.2 170 F 
558(7) 36 1 35 12 16 152 88 7.1 73 103 170 F 
558(8) 45 5 44 21 25 125 71 6.5 70 110 170 F 
558(10) 28 1 27 10 12 128 79 6.4 69 103.4 170 F 
558(11) 33 2 34* 17 12 166 102 6.0 69 103.4 170 F 
572(2) 31 5 30 12 12 116 66 5.4 100 82.4 180 M 
572(6) 29 5 24 7 9 119 72 6.0 97 82.4 180 M 
572(7) 26 2 24 8 7 112 72 6.8 100 82.4 180 M 
572(9) 26 2 23 10 9 109 71 6.0 95 82.4 180 M 
572(10) 28 1 24 10 9 112 73 6.1 90 82.4 180 M 
572(11) 17 4 20* 10 10 108 67 5.0 88 83 180 M 
572(13) 22 1 16 9 5 122 71 6.4 98 82 180 M 
572(14) 19 4 17 9 7 115 73 6.3 97 82.4 180 M 
794 38 6 39* 17 21 98 57 4.9 84 44 174 F 
839 25 1 18 9 7 135 84 5.9 91 83 170 M 
 30 ± 6 4 ± 3 30 ± 6 13 ± 3 11 ± 4 104 ± 46 65 ± 29 5.2 ± 1.6 92 ± 12 82 ± 13 171 ± 7   
* indicates pulmonary artery pressure that was reduced to be less than that of the pressure in the right 
ventricle only when calculating nominal parameter values. (⋅) in the first column refers to the RHC 
number for each patient. Note that some RHCs were excluded because they were missing at least one of 
the required measures. 
Table S2. Optimized parameter values for both the sensitivity-based and physiologically-based parameter 
sets for each patient. 
 
Parameter Units 
Patient Number 
 60 66 233 266 363 456 558 572 794 839 
67($8 
9:# mL;< 0.0371 0.0225 0.0313 0.0357 0.0366 0.0356 0.0297 0.031 0.0473 0.0317 9"# mL;< 0.0274 0.0153 0.0228 0.0321 0.0304 0.0288 0.0208 0.0245 0.0392 0.0232 =>?,$% mmHgmL  1.2345 0.2037 0.2751 0.4349 0.2814 0.8777 0.1961 0.5864 1.8014 0.1977 =>?,$A mmHgmL  0.0213 0.0089 0.0275 0.019 0.0244 0.022 0.0204 0.0168 0.0409 0.0118 B$A: mmHg ⋅ smL  0.04 0.093 0.0502 0.1029 0.1671 0.0613 0.0408 0.0698 0.0365 0.0538 =>?,%( mmHgmL  0.8969 0.8204 0.9486 1.313 0.9596 0.7835 0.7832 1.1666 0.8884 0.963 B?C? mmHg ⋅ smL  1.2353 0.9407 0.8983 0.9763 1.2109 0.9158 0.453 0.9303 0.8495 1.0843 B$# mmHg ⋅ smL  0.0037 0.0048 0.0103 0.0103 0.007 0.0238 0.0026 0.0036 0.0042 0.0167 
6D($8 
=>?,:# mmHgmL  1.3789 1.8025 1.7476 1.7338 0.9132 0.9709 2.0125 1.0936 0.8718 1.5398 EF,:# mL 5.6414 5.6687 8.2928 7.4578 8.0083 5.5319 6.9461 6.5647 6.4109 5.2299 =>?,"# mmHgmL  0.5311 0.7005 0.6942 0.4051 0.2786 0.4821 1.2041 0.3538 0.4015 0.4086 =>?,$% mmHgmL  1.2453 0.2105 0.2782 0.4302 0.279 1.0152 0.2012 0.5836 0.9794 0.1989 =>?,$A mmHg mL  0.0225 0.0081 0.0273 0.0207 0.0266 0.0233 0.0196 0.0168 0.0539 0.0118 B$A: mmHg ⋅ smL  0.04 0.0944 0.0499 0.1024 0.1668 0.0578 0.0417 0.0701 0.0406 0.0541 =>?,%( mmHgmL  0.8876 0.8299 0.946 1.3055 0.9681 0.7742 0.7869 1.1636 0.8684 0.9706 B?C? mmHg ⋅ smL  1.2324 0.9453 0.8984 0.9737 1.2118 0.9145 0.4539 0.9298 0.8458 1.0845 B$# mmHg ⋅ smL  0.0037 0.0056 0.0105 0.0097 0.0071 0.0225 0.0025 0.0039 0.006 0.0163 
The RHC dataset that was selected for each patient was the first RHC dataset available post-transplant. 
  
Figure S1 
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